PeptiDream Inc. (TYO:4587)
1,182.50
-23.50 (-1.95%)
Apr 17, 2026, 3:30 PM JST
PeptiDream Market Cap
PeptiDream has a market cap or net worth of 152.8 billion as of April 17, 2026. Its market cap has decreased by -44.91% in one year.
Market Cap
152.80B
Enterprise Value
141.82B
Revenue
18.52B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,182.50
Market Cap Chart
Since June 11, 2013, PeptiDream's market cap has increased from 74.10B to 152.80B, an increase of 106.21%. That is a compound annual growth rate of 5.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 152.80B | -28.61% |
| Dec 30, 2025 | 214.04B | -37.55% |
| Dec 30, 2024 | 342.76B | 77.91% |
| Dec 29, 2023 | 192.66B | -28.55% |
| Dec 30, 2022 | 269.66B | -18.39% |
| Dec 30, 2021 | 330.41B | -49.84% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GNI Group | 187.66B |
| SanBio Company | 163.17B |
| Takara Bio | 137.51B |
| Nxera Pharma | 91.67B |
| Oncolys BioPharma | 83.72B |
| Cuorips | 58.22B |
| Healios K.K. | 49.95B |
| Japan Tissue Engineering | 24.98B |